|
|
 |
| |
|
Home > Drug Companies > Ortho Biotech Products, L.P.
Ortho Biotech Products, L.P.
Ortho Biotech Products, L.P. is a leading biopharmaceutical company that provides innovative products and services designed to help enhance the lives of individuals with serious chronic illnesses. They market a prescription medication for chemotherapy-related anemia in patients with most types of cancer, for kidney disease patients with anemia who are not on dialysis, for anemia induced containing regimens in HIV patients, and for patients undergoing elective, non cardiac, non vascular surgery who are anemic. More than two million patients in the United States alone have been treated with their products.
The firm creates Tibotec Therapeutics, a new division that enables the company to sharpen its focus, strengthen its portfolio and leverage new opportunities to drive sustainable leadership positions in supportive care and oncology therapeutics, as well as build commercial capabilities in HIV.
The firm receives FDA approval for Procrit to treat anemia associated with cancer chemotherapy for most types of cancer. The firm introduces Leustatin as the company’s first oncology drug, for the treatment of active hairy cell leukemia. Leustatin is the National Cancer Institute’s recommended treatment for this rare form of cancer. Important Safety Information.
Their products treat some of the world's most serious health problems. They are proud that their treatments help enhance the health of patients. They at Ortho Biotech Products, L.P., are a team of people with headquarters in Bridgewater, New Jersey. They are a member of the Johnson & Johnson Family of Companies. They have a passion for the work they do, and compassion for the patients and providers they serve.
Their business teams are comprised of individuals with diverse skill sets who devise solutions that effectively address unique business needs and health care challenges. This site takes reasonable steps to protect personally identifiable information as you transmit it to their site and to protect such information from loss, misuse, and unauthorized access, disclosure, alteration, or destruction.
Back to Drug Companies
|
|
|
|
|
|
|
|